These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7384088)

  • 41. A novel model of bone-metastatic prostate cancer in immunocompetent mice.
    Power CA; Pwint H; Chan J; Cho J; Yu Y; Walsh W; Russell PJ
    Prostate; 2009 Nov; 69(15):1613-23. PubMed ID: 19585491
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential metastasis-associated gene analysis of prostate carcinoma cells derived from primary tumor and spontaneous lymphatic metastasis in nude mice with orthotopic implantation of PC-3M cells.
    Chu JH; Sun ZY; Meng XL; Wu JH; He GL; Liu GM; Jiang XR
    Cancer Lett; 2006 Feb; 233(1):79-88. PubMed ID: 15885894
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of metastatic potential in prostate carcinoma: an in vivo model.
    Angelucci A; Gravina GL; Rucci N; Festuccia C; Muzi P; Vicentini C; Teti A; Bologna M
    Int J Oncol; 2004 Dec; 25(6):1713-20. PubMed ID: 15547709
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Viable circulating metastatic cells produced in orthotopic but not ectopic prostate cancer models.
    Glinskii AB; Smith BA; Jiang P; Li XM; Yang M; Hoffman RM; Glinsky GV
    Cancer Res; 2003 Jul; 63(14):4239-43. PubMed ID: 12874032
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of cyclooxygenase-2 in prostate carcinoma.
    Yoshimura R; Sano H; Masuda C; Kawamura M; Tsubouchi Y; Chargui J; Yoshimura N; Hla T; Wada S
    Cancer; 2000 Aug; 89(3):589-96. PubMed ID: 10931458
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Osteoblastic metastasis in advanced prostate cancer.
    Koutsilieris M
    Anticancer Res; 1993; 13(2):443-9. PubMed ID: 8517661
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Metastasis of prostate carcinoma in a hernial sac].
    Pagliere H; Soldano E; Scorticatti C
    Rev Argent Urol Nefrol; 1966; 35(1):37-8. PubMed ID: 5988990
    [No Abstract]   [Full Text] [Related]  

  • 50. Prostate tumor progression and metastasis.
    Ware JL
    Biochim Biophys Acta; 1987 Nov; 907(3):279-98. PubMed ID: 3314999
    [No Abstract]   [Full Text] [Related]  

  • 51. Improvement of the model systems.
    Skipper HE
    Cancer Res; 1969 Dec; 29(12):2329-33. PubMed ID: 5369680
    [No Abstract]   [Full Text] [Related]  

  • 52. Conference summary: First International Workshop on Animal models of Prostate Cancer.
    Waters DJ; Bostwick DG; Murphy GP
    Prostate; 1998 Jun; 36(1):47-8. PubMed ID: 9650915
    [No Abstract]   [Full Text] [Related]  

  • 53. Lobund-Wistar rat model of prostate cancer in man.
    Pollard M
    Prostate; 1998 Sep; 37(1):1-4. PubMed ID: 9721062
    [No Abstract]   [Full Text] [Related]  

  • 54. The Dunning model.
    Tennant TR; Kim H; Sokoloff M; Rinker-Schaeffer CW
    Prostate; 2000 Jun; 43(4):295-302. PubMed ID: 10861749
    [No Abstract]   [Full Text] [Related]  

  • 55. Requirements of in vitro model systems.
    Merchant DJ
    Prog Clin Biol Res; 1980; 37():3-7. PubMed ID: 7384088
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Requirements for an idealized animal model of prostatic cancer.
    Coffey DS; Isaacs JT
    Prog Clin Biol Res; 1980; 37():379-91. PubMed ID: 7384094
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improved metastatic animal model of human prostate carcinoma using surgical orthotopic implantation (SOI).
    Chang XH; Fu YW; Na WL; Wang J; Sun H; Cai L
    Anticancer Res; 1999; 19(5B):4199-202. PubMed ID: 10628375
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vivo models of prostate cancer metastasis to bone.
    Singh AS; Figg WD
    J Urol; 2005 Sep; 174(3):820-6. PubMed ID: 16093963
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetically modified mice and their use in developing therapeutic strategies for prostate cancer.
    Kasper S; Smith JA
    J Urol; 2004 Jul; 172(1):12-9. PubMed ID: 15201729
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [In vitro and in vivo models developed from human prostatic cancer].
    Bladou F; Gleave ME; Penault-Llorca F; Serment G; Lange PH; Vessella RL
    Prog Urol; 1997 Jun; 7(3):384-96. PubMed ID: 9273065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.